English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Nonmuscle invasive bladder cancer is a common malignancy. After transurethral resection, intravesical administration of Bacillus Calmette-Guérin (BCG) is a treatment that is generally used for non-muscle-invasive bladder cancer. Intravesical BCG treatment decrease the number of tumor recurrence and progression. The complications of BCG therapy are important that clinicians are aware of these. Serious complications are uncommon with BCG treatment, but life-threatening side effects such as sepsis, hepatitis and pneumonia may occur. The person who applies the intravesical BCG must be very careful throughout the entire administration procedure. We present a patient whom an intravenous BCG infusion was inadvertently administered and the patient was successfully treated with anti-tuberculin therapy. A review of available literature on the possible complications of this treatment have been performed.

turkish journal of medical research/türkiye klinikleri journal of case reports

Disseminated Bacillus Calmette-Guérin (BCG) Infection Caused By Inadvertent Intravenous Infusion of BCG for the Treatment of Bladder Cancer: Case Report